Benefits of post-Myocardial Infarction adherence

Poor adherence to certain cardioprotective drugs – including aspirin and statins – 'is associated with a marked risk increase in all-cause mortality' among people who survived acute myocardial infarction, according to a study that enrolled 4655 patients with a mean age of 66.3 years.

During an 8 year (median 4.53 years) follow up, 18.6% of the patients died. Overall, 78.8% of patients were adherent (took at least 80% of the doses) to at least one medication. Only 18.2% adhered to four medications: beta-blockers, aspirin, statins, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).